Skip to main content
. 2023 Mar 28;30(11):1568–1579. doi: 10.5551/jat.64159

Supplementary Table 3. Clinical characteristics between the low AUC and high AUC groups among patients with CVCS.

All (n= 34) Low AUC (n= 17) High AUC (n= 17) p
Age (year) 69.4±9.2 70.9±10.0 67.8±8.4 0.342
Male (%) 26 (78.1) 13 (76.5) 13 (76.5) 0.656
Smoking (%) 22 (64.7) 12 (70.6) 10 (58.8) 0.473
HT (%) 34 (100.0) 17 (100.0) 17 (100.0) -
DM (%) 16 (47.1) 7 (41.2) 9 (52.9) 0.492
DLp (%) 16 (47.1) 6 (35.3) 10 (58.8) 0.169
SBP (mmHg) 145.2±19.3 144.5±16.9 145.9±22.0 0.828
DBP (mmHg) 68.4±11.1 69.7±10.8 67.1±11.5 0.503
ACE-I/ARB (%) 23 (45.3) 11 (64.7) 12 (70.6) 0.714
Statin (%) 23 (67.6) 10 (58.8) 13 (76.5) 0.271
Lanthanum carbonate (%) 16 (47.1) 7 (41.2) 9 (52.9) 0.492
Calcium carbonate (%) 18 (52.9) 10 (58.8) 8 (47.1) 0.492
Sevelamer (%) 0 (0.0) 0 (0.0) 0 (0.0) -
Bixalomer (%) 0 (0.0) 0 (0.0) 0 (0.0) -
Vitamin D (%) 11 (32.4) 4 (23.5) 7 (41.2) 0.271
Warfarin (%) 3 (8.8) 2 (11.8) 1 (5.9) 0.500
Hb (g/dL) 8.7±1.2 8.7±1.3 8.9±1.2 0.568
cCa (mg/dL) 8.8±0.5 8.8±0.7 8.7±0.4 0.469
P (mg/dL) 5.7±1.3 5.3±1.4 6.2±0.9 0.029
Albumin (g/dL) 3.3±0.4 3.2±0.4 3.4±0.5 0.425
Intact PTH (pg/mL) 235.0 (133.0 – 335.0) 262.0 (109.0 – 389.0) 231.0 (157.0 – 330.0) 0.973
CACS 549.7 (141.8 – 1221.2) 480.7 (142.5 – 1840.9) 618.7 (131.8 – 1074.9) 0.518
CVCS 2.0 (0.0 – 3.0) 2.0 (0.5 – 4.0) 2.0(0.0 – 2.5) 0.231

AUC, area under the curve; HT, hypertension; DM, diabetes mellitus; DLp, dyslipidemia; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II type 1 receptor blocker; Hb, hemoglobin; cCa, corrected calcium; P, phosphate; PTH, parathyroid hormone; CACS, coronary artery calcium score; CVCS, cardiac valvular calcification score.

Values are presented as mean±SD or median (interquartile range).